JournalDOAJCrossrefOpenAlex
Signal Transduction and Targeted Therapy
Metadata for this journal is being enriched from connected scholarly data sources.
Journal information
- Publisher
- Nature Portfolio
- ISJN
- STTTH
- Subjects
- Biology (General) · Cancer Immunotherapy and Biomarkers · CAR-T cell therapy research · cell biology · computational chemistry · COVID-19 Clinical Research Studies · Epigenetics and DNA Methylation · Immune Cell Function and Interaction · Immune cells in cancer · medicinal chemistry · Medicine · molecular biology · pharmacology · R · RNA modifications and cancer · SARS-CoV-2 and COVID-19 Research · systems biology
- Country
- GB
- Languages
- EN
- ISSN
- —
- E-ISSN
- 2059-3635
- ISSN-L
- 2059-3635
- Open access
- Yes
- OA since
- 2016
- Publication years
- 1975–2026
- Website
- Visit journal ↗
APC records
- OPENALEX · 2026
- 3,090 EUR
- OPENALEX · 2026
- 2,790 GBP
- OPENALEX · 2026
- 3,790 USD
- DOAJ · 2026
- 3,390 EUR
- DOAJ · 2026
- 3,090 GBP
- DOAJ · 2026
- 4,170 USD